Get started
Author

Raffaella Gentilella

Observed names: Gentilella, Raffaella, R Gentilella, R. Gentilella
Institution: Eli Lilly (Italy)
OpenAlex ID: A5060140104
Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus
2017 · G. Reach, V. Pechtner, et al. · Diabetes & Metabolism · 262
PDF
Glucagon‐like peptide‐1 receptor agonists in type 2 diabetes treatment: are they all the same?
2018 · Raffaella Gentilella, Valeria Pechtner, et al. · Diabetes/Metabolism Research and Reviews · 238
Fracture Incidence and Characterization in Patients on Osteoporosis Treatment: The ICARO Study
2006 · Silvano Adami, Giancarlo Isaia, et al. · Journal of Bone and Mineral Research · 125
PDF
Exenatide: a review from pharmacology to clinical practice
2009 · R. Gentilella, C. Bianchi, et al. · Diabetes Obesity and Metabolism · 108
Growth Hormone Secretion and Leptin in Morbid Obesity before and after Biliopancreatic Diversion: Relationships with Insulin and Body Composition
2004 · L. De Marinis, A. Bianchi, et al. · The Journal of Clinical Endocrinology & Metabolism · 96
Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement
2018 · Francesco Giorgino, Alfred Penfornis, et al. · Patient Preference and Adherence · 66
PDF
Outcome of pregnancy in type 1 diabetic patients treated with insulin lispro or regular insulin: an Italian experience
2008 · Annunziata Lapolla, M. G. Dalfrà, et al. · Acta Diabetologica · 57
Insulin therapy in neonatal diabetes mellitus: a review of the literature
2017 · Ivana Rabbone, Fabrizio Barbetti, et al. · Diabetes Research and Clinical Practice · 37
Osteoporosis treatment and fracture incidence: the ICARO longitudinal study
2008 · S. Adami, G. Isaia, et al. · Osteoporosis International · 31
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: A retrospective evaluation of 50 patients
2002 · L. De Marinis, A. Mancini, et al. · Metabolism · 26
Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy
2019 · Kristina S. Boye, Louis S. Matza, et al. · Journal of Medical Economics · 22
PDF
Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes
2018 · Louis Matza, Kristina Boye, et al. · Patient Preference and Adherence · 20
PDF
Short‐ and long‐term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism
2019 · Antonio Bianchi, Antonella Giampietro, et al. · Journal of Neuroendocrinology · 19
Effects of galanin on growtn hormone and prolactin secretion in anorexia nervosa
2000 · Laura De Marinis, Antonio Mancini, et al. · Metabolism · 19
Unmet needs among patients with Type 2 diabetes and secondary failure to oral anti-diabetic agents
2008 · D. Pitocco, D. Valle, et al. · Journal of Endocrinological Investigation · 14
Dulaglutide is an effective treatment for lowering HbA1c in patients with type 2 diabetes regardless of body mass index
2019 · Raffaella Gentilella, Giorgio Sesti, et al. · Diabetes Obesity and Metabolism · 13
Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents
2019 · Raffaella Gentilella, Irene Romera, et al. · Diabetes Therapy · 11
PDF
Personalized intensification of insulin therapy in type 2 diabetes – does a basal–bolus regimen suit all patients?
2016 · D. Giugliano, J. Sieradzki, et al. · Current Medical Research and Opinion · 9
GH deficiency syndrome in elderly patients.
2002 · L De Marinis, A Mancini, et al. · PubMed · 9
Evaluation of pre- and postprandial growth hormone (GH)-releasing hormone-induced GH response in subjects with persistent body weight normalisation after biliopancreatic diversion
1998 · L De Marinis, A Mancini, et al. · International Journal of Obesity · 9
Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data
2012 · Antonio Ceriello, Francesco Cremasco, et al. · Expert Opinion on Pharmacotherapy · 8
Role of Food Intake in the Modulation of Hexarelin-Induced Growth Hormone Release in Normal Human Subjects
2000 · L. De Marinis, A. Mancini, et al. · Hormone and Metabolic Research · 8
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
2021 · Luis-Emilio García-Pérez, Kristina S. Boye, et al. · Diabetes Therapy · 7
PDF
Changing the approach to type 2 diabetes treatment: A comparison of glucagon‐like peptide‐1 receptor agonists and sulphonylureas across the continuum of care
2021 · Marco Orsini Federici, Raffaella Gentilella, et al. · Diabetes/Metabolism Research and Reviews · 7
PDF
Physiological role of the opioid-cholinergic interaction in growth hormone neuroregulation: Effect of sex and food intake
1997 · Laura de Marinis, Antonio Mancini, et al. · Metabolism · 7
Works count: 48
Citation count: 1,247
H-index: 14
I10-index: 17
Year
Topic
Type